Georgia Erbez

Georgia Erbez (finance chief) discloses dealings in 2 companies, chiefly Codexis, Inc. and Harpoon Therapeutics, Inc. Between 22 September 2021 and 12 October 2026, the trades on record add up to 6 filings.

The open-market side counts 1 purchase for €71k alongside 3 sales for €25k. Taken together, the purchases exceed the sales by €46k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 2 share grants. 2026 to date brings no purchases and 2 sales.

The record was last updated on 14 October 2026 with an open-market sale (€7,684) in Codexis, Inc. The last purchase on record was published on 22 September 2021, which is 1,852 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.